Have a personal or library account? Click to login
Predictive Value of Systemic Immune-inflammation Index in Determining Mortality in COVID-19 Patients Cover

Predictive Value of Systemic Immune-inflammation Index in Determining Mortality in COVID-19 Patients

Open Access
|Aug 2022

References

  1. Zhu N, Zhang D, Wang W, Li X, Yang B, Song J, et al. A Novel Coronavirus from Patients with Pneumonia in China, 2019. The New England journal of medicine 2020;382(8):727-33.
  2. Guan WJ, Ni ZY, Hu Y, Liang WH, Ou CQ, He JX, et al. Clinical Characteristics of Coronavirus Disease 2019 in China. The New England journal of medicine 2020;382(18):1708-20.
  3. Xiong S, Liu L, Lin F, Shi J, Han L, Liu H, et al. Clinical characteristics of 116 hospitalized patients with COVID-19 in Wuhan, China: a single-centered, retrospective, observational study. BMC infectious diseases 2020;20(1):787.
  4. Wang W, Xu Y, Gao R, Lu R, Han K, Wu G, et al. Detection of SARS-CoV-2 in Different Types of Clinical Specimens. Jama 2020;323(18):1843-4.
  5. Zhou F, Yu T, Du R, Fan G, Liu Y, Liu Z, et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet (London, England) 2020;395(10229):1054-62.
  6. Liu Y, Du X, Chen J, Jin Y, Peng L, Wang HHX, et al. Neutrophilto-lymphocyte ratio as an independent risk factor for mortality in hospitalized patients with COVID-19. The Journal of infection 2020;81(1):e6-e12.
  7. Al-Samkari H, Karp Leaf RS, Dzik WH, Carlson JCT, Fogerty AE, Waheed A, et al. COVID-19 and coagulation: bleeding and thrombotic manifestations of SARS-CoV-2 infection. Blood 2020;136(4):489-500.
  8. Chen JH, Zhai ET, Yuan YJ, Wu KM, Xu JB, Peng JJ, et al. Systemic immune-inflammation index for predicting prognosis of colorectal cancer. World journal of gastroenterology 2017;23(34):6261-72.
  9. Ozbek E, Besiroglu H, Ozer K, Horsanali MO, Gorgel SN. Systemic immune inflammation index is a promising noninvasive marker for the prognosis of the patients with localized renal cell carcinoma. International urology and nephrology 2020;52(8):1455-63.
  10. Yang R, Chang Q, Meng X, Gao N, Wang W. Prognostic value of Systemic immune-inflammation index in cancer: A meta-analysis. Journal of Cancer 2018;9(18):3295-302.
  11. Weiss SR, Leibowitz JL. Coronavirus pathogenesis. Advances in virus research 2011;81:85-164.
  12. Li W, Moore MJ, Vasilieva N, Sui J, Wong SK, Berne MA, et al. Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus. Nature 2003;426(6965):450-4.
  13. [The epidemiological characteristics of an outbreak of 2019 novel coronavirus diseases (COVID-19) in China]. Zhonghua Liu Xing Bing Xue Za Zhi 2020;41(2):145-51.
  14. Güneş M, Umul M, Altok M, Akyuz M, İşoğlu CS, Uruc F, et al. Predictive role of hematologic parameters in testicular torsion. Korean journal of urology 2015;56(4):324-9.
  15. Wu J, Yan L, Chai K. Systemic immune-inflammation index is associated with disease activity in patients with ankylosing spondylitis. Journal of clinical laboratory analysis 2021;35(9):e23964.
  16. Tanacan E, Dincer D, Erdogan FG, Gurler A. A cutoff value for the Systemic Immune-Inflammation Index in determining activity of Behçet disease. Clinical and experimental dermatology 2021;46(2):286-91.
  17. Kim Y, Choi H, Jung SM, Song JJ, Park YB, Lee SW. Systemic immune-inflammation index could estimate the cross-sectional high activity and the poor outcomes in immunosuppressive drug-naïve patients with antineutrophil cytoplasmic antibody-associated vasculitis. Nephrology (Carlton, Vic) 2019;24(7):711-7.
  18. Li Q, Cao Y, Chen L, Wu D, Yu J, Wang H, et al. Hematological features of persons with COVID-19. Leukemia 2020;34(8):2163-72.
  19. Guo T, Fan Y, Chen M, Wu X, Zhang L, He T, et al. Cardiovascular Implications of Fatal Outcomes of Patients With Coronavirus Disease 2019 (COVID-19). JAMA cardiology 2020;5(7):811-8.
  20. Yang AP, Liu JP, Tao WQ, Li HM. The diagnostic and predictive role of NLR, d-NLR and PLR in COVID-19 patients. International immunopharmacology 2020;84:106504.
  21. Xue G, Gan X, Wu Z, Xie D, Xiong Y, Hua L, et al. Novel serological biomarkers for inflammation in predicting disease severity in patients with COVID-19. International immunopharmacology 2020;89(Pt A):107065.
  22. Fois AG, Paliogiannis P, Scano V, Cau S, Babudieri S, Perra R, et al. The Systemic Inflammation Index on Admission Predicts In-Hospital Mortality in COVID-19 Patients. Molecules (Basel, Switzerland) 2020;25(23).
  23. Salman E, Çelikbilek N, Aydoğan S, Özdem B, Gökay S, Kırca F, et al. [Investigation of the Relationship of Systemic Immune-Inflammation Index, C-Reactive Protein and Interleukin-6 with Viral Dynamics in Patients with COVID-19]. Mikrobiyoloji bulteni 2021;55(4):539-52.
  24. Lorente L, Martín MM, Argueso M, Solé-Violán J, Perez A, Marcos YRJA, et al. Association between red blood cell distribution width and mortality of COVID-19 patients. Anaesthesia, critical care & pain medicine 2021;40(1):100777.
  25. Vogels Y, Pouwels S, van Oers J, Ramnarain D. Characteristics and Risk Factors Associated With Mortality in Critically Ill Patients With COVID-19. Cureus 2021;13(4):e14442.
  26. Mignot-Evers L, Raaijmakers V, Buunk G, Brouns S, Romano L, van Herpt T, et al. Comparison of SIRS criteria and qSOFA score for identifying culture-positive sepsis in the emergency department: a prospective cross-sectional multicentre study. BMJ open 2021;11(6):e041024.
  27. Zheng Z, Peng F, Xu B, Zhao J, Liu H, Peng J, et al. Risk factors of critical & mortal COVID-19 cases: A systematic literature review and meta-analysis. The Journal of infection 2020;81(2):e16-e25.
  28. Chen N, Zhou M, Dong X, Qu J, Gong F, Han Y, et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet (London, England) 2020;395(10223):507-13.
  29. Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet (London, England) 2020;395(10223):497-506.
  30. Zhang JJ, Cao YY, Tan G, Dong X, Wang BC, Lin J, et al. Clinical, radiological, and laboratory characteristics and risk factors for severity and mortality of 289 hospitalized COVID-19 patients. Allergy 2021;76(2):533-50.
  31. Wu J, Wu X, Zeng W, Guo D, Fang Z, Chen L, et al. Chest CT Findings in Patients With Coronavirus Disease 2019 and Its Relationship With Clinical Features. Investigative radiology 2020;55(5):257-61.
  32. Gabarre P, Dumas G, Dupont T, Darmon M, Azoulay E, Zafrani L. Acute kidney injury in critically ill patients with COVID-19. Intensive care medicine 2020;46(7):1339-48.
  33. Luo L, Fu M, Li Y, Hu S, Luo J, Chen Z, et al. The potential association between common comorbidities and severity and mortality of coronavirus disease 2019: A pooled analysis. Clinical cardiology 2020;43(12):1478-93.
  34. Li X, Pan X, Li Y, An N, Xing Y, Yang F, et al. Cardiac injury associated with severe disease or ICU admission and death in hospitalized patients with COVID-19: a meta-analysis and systematic review. Critical care (London, England) 2020;24(1):468.
  35. Huang I, Pranata R, Lim MA, Oehadian A, Alisjahbana B. C-reactive protein, procalcitonin, D-dimer, and ferritin in severe coronavirus disease-2019: a meta-analysis. Therapeutic advances in respiratory disease 2020;14:1753466620937175.
  36. Zhang L, Yan X, Fan Q, Liu H, Liu X, Liu Z, et al. D-dimer levels on admission to predict in-hospital mortality in patients with Covid-19. Journal of thrombosis and haemostasis : JTH 2020;18(6):1324-9.
DOI: https://doi.org/10.2478/jccm-2022-0013 | Journal eISSN: 2393-1817 | Journal ISSN: 2393-1809
Language: English
Page range: 156 - 164
Submitted on: Oct 31, 2021
|
Accepted on: Jun 1, 2022
|
Published on: Aug 12, 2022
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year

© 2022 Tahsin Karaaslan, Esra Karaaslan, published by University of Medicine, Pharmacy, Science and Technology of Targu Mures
This work is licensed under the Creative Commons Attribution 4.0 License.